Douglas J. Hartman, MD
Assistant Professor of Pathology
Dr. Hartman is a member of the Division of Anatomic Pathology.
Presbyterian University Hospital
200 Lothrop Street
Pittsburgh, PA 15213
Office Telephone: 412-864-3552
- BA - 1999, Xavier University
- MD - 2004, University of Cincinnati College of Medicine
- AP/CP Pathology Residency - 2008, University Hospitals of Cleveland/Case Western Reserve University
- Pathology Fellowship - 2009, Gastrointestinal Pathology, University of Pittsburgh Medical Center
Clinical ExpertiseDr. Hartman is an Academic Surgical Pathologist with a subspecialty interest and focus in Gastrointestinal and Pancreatic pathology. He also consults on surgical pathology cases involving the luminal GI tract and pancreas.
CertificationsDiplomate of the American Board of Pathology in combined Anatomic Pathology and Clinical Pathology
SpecialtiesSurgical Pathologist with subspecialty interest and training in gastrointestinal / pancreatic pathology
Research InterestsMy current primary research interests are in the field of idiopathic inflammatory bowel disease: underlying mechanisms, molecular pathogenesis of dysplasia development; associated disorders; and post-surgical complications. Other areas of research include assessing the effect of neoadjuvant therapy on pancreatic cancer, molecular abnormalities in colon cancer, and the application of pathology informatics. I am a co-investigator on institutional grants.
Selected PublicationsView Dr. Hartman's publications on PubMed
- Barrie AM, El Mourabet M, Weyant K, Clarke K, Gajendran M, Rivers C, Park SY, Hartman DJ, Saul M, Reguiero M, Yadav D, Binion DG. Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Digestive Diseases and Sciences, in press.
- Hartman DJ, Slivka AS, Giusto DA, Krasinskas AM. Indeterminate biliary strictures: Tissue yield and diagnostic efficacy of fluoroscopic and cholangioscopic techniques. Accepted for Clin Gastro and Hepatol.
- Bista RJ, Wang P, Bhargava R, Hartman DJ, Uttam S, Brand RE, Liu Y. Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer. Accepted for Breast Cancer Research and Treatment
- Bista RJ, Uttam S, Hartman DJ, Qiu W, Yu J, Zhang L, Brand RE, Liu Y. Investigation of nuclear nano-morphology marker as a biomarker for cancer risk assessment using a mouse model. J. Biomed. Opt. 2012 Jun; 17(6), 066014. doi:10.1117/1.JBO.17.7.066014
- Hartman DJ, Davison JM, Foxwell TJ, Nikiforova MN, Chiosea SI. Mutant Allele Specific Imbalance Modulates Prognostic Impact of KRAS Mutations in Colorectal Adenocarcinoma and is Associated with Worse Overall Survival. Int J Cancer. 2012 Jan 30. doi: 10.1002/ijc.27461.
- Goodell PP, Krasinskas AM, Davison JM, Hartman DJ. Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors. Am J Clin Pathol. 2012 Apr;137(4):576-82.
- Hartman DJ and Owens SR. Are routine ancillary stains required to diagnose Helicobacter infection on gastric biopsies? An institutional quality assurance review. Am J Clin Pathol. 2012 Feb;137(2):255-60.
- Hartman DJ, Krasinskas AM. Assessment of treatment effect in pancreatic cancer. Arch Pathol Lab Med 2012 Jan;136(1):100-9.
- Uttam S, Bista RK, Hartman DJ, Brand RE, Liu Y. Correction of stain variations in nuclear refractive index of clinical histology specimens. J. Biomed. Opt. 2011 November; 16(11): 116013; doi:10.1117/1.3650306 (6 pages)
- Bista RK, Uttam S, Wang P, Staton K, Choi S, Bakkenist CJ, Hartman DJ, Brand RE, Liu Y. Quantification of nanoscale nuclear refractive index changes during the cell cycle. J. Biomed. Opt. 2011 July; 16(7): 070503; doi:10.1117/1.3597723 (3 pages)
- Qiu W, Wu B, Buchanan M, Reguiero M, Hartman DJ, Schoen R, Yu J, Zhang L. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest 2011 May 2;121(5):1722-32.